Research on the combined predictors of refractory mycoplasma pneumonia in children

FU Shuai, QIN Xuan-guang

Chinese Journal of Child Health Care ›› 2021, Vol. 29 ›› Issue (4) : 455-457.

PDF(382 KB)
PDF(382 KB)
Chinese Journal of Child Health Care ›› 2021, Vol. 29 ›› Issue (4) : 455-457. DOI: 10.11852/zgetbjzz2020-1536
Experience Exchange

Research on the combined predictors of refractory mycoplasma pneumonia in children

  • FU Shuai, QIN Xuan-guang
Author information +
History +

Abstract

Objective To study the risk factors that can be used to distinguish children's refractory mycoplasma pneumonia (RMPP) from mycoplasma pneumonia (MPP),thus to determine the combined predictors for predicting RMPP,so as to provide basis for customizing accurate treatment and medication plan for RMPP children. Methods A total of 141 children with MPP admitted to Beijing Chaoyang Hospital Affiliated to Capital Medical University from January 1st,2016 to December 31st,2018 were included,and clinical data and laboratory examination data were collected. The patients were divided into MPP group and RMPP group according to the therapeutic efficacy of the first 3 days. The risk factors related to RMPP were preliminarily screened out by univariate analysis,and a multivariate Logistic regression model was established and independent risk factors were selected through stepwise regression. Finally,the receiver operating characteristic curve (ROC) of combined factors was drawn for prediction efficiency analysis. Results There were 85 cases of MPP and 56 cases of RMPP among 141 children.Age,pleural effusion,cough duration,C-creactive protein (CRP),erythrocyte sedimentation rate (ESR),lymphocyte count (LY)and percentage of lymphocytes (LY%) were significantly different between MPP group and RMPP group (P<0.05). Pleural effusion,fever duration,cough duration,CRP and LY% finally entered the prediction model of RMPP,with AUC of 0.834(95%CI:0.768—0.900),Youden index of 0.522 at the maximum. And the sensitivity and specificity were 80.4% and 71.8%,respectively. Conclusion This study constructs a combined model for predicting RMPP with pleural effusion,fever duration,cough duration,CRP,LY%,which has clinical guiding significance for the predictive diagnosis of RMPP and the use of glucocorticoids.

Key words

mycoplasma pneumonia / refractory mycoplasma pneumonia / combined predictor

Cite this article

Download Citations
FU Shuai, QIN Xuan-guang. Research on the combined predictors of refractory mycoplasma pneumonia in children[J]. Chinese Journal of Child Health Care. 2021, 29(4): 455-457 https://doi.org/10.11852/zgetbjzz2020-1536

References

[1] 中华人民共和国国家健康委员会,国家中医药局. 儿童社区获得性肺炎诊疗规范(2019年版)[J].中华临床感染病杂志,2019,12(1):6-13.
[2] 中华医学会儿科学分会临床检验学组.儿童肺炎支原体呼吸道感染实验室诊断中国专家共识[J].中华检验医学杂志,2019,42(7):507-513.
[3] 陈志敏,尚云晓,赵顺英,等.儿童肺炎支原体肺炎诊治专家共识(2015年版)[J].中华实用儿科临床杂志,2015,30(17):1304-1308.
[4] 闻玉梅.现代医学微生物学[M].上海:上海医科大学出版社,1999:592-602.
[5] 姜艳群,孔小行.146例儿童感染性胸腔积液病因分析[J].中国感染控制杂志,2013,12(6):409-411.
[6] 郑宝英,曹玲.儿童支原体肺炎合并胸腔积液诊断及处理[J].中国实用儿科杂志,2017,32(3):171-174.
[7] 李雪冰,荀春铮.儿童肺炎支原体感染后咳嗽发作时辰、病程分布特征及其与中医证型的相关性[J].中医药导报,2019,25(24):57-58,63.
[8] 陈艳丽.血清CRP在小儿支原体肺炎诊治中的价值[J].医学信息,2019,32(18):181-182.
[9] 刘金荣,彭芸,杨海明,等.难治性肺炎支原体肺炎的表现特征和判断指标探讨[J].中华儿科杂志,2012,50(12):915-918.
[10] 李晓娟,安俊杰.肺炎支原体感染患儿免疫球蛋白、补体及T淋巴细胞亚群的水平[J].中国临床医生杂志,2019,47(3):361-363.
[11] 秦正积,沈毅,崔晓莉,等.Logistic回归在疾病多指标联合诊断中的应用[J].中国卫生统计,2014,31(1):116-117.
[12] Tagliabue C,Salvatore CM,Techasaensiri C,et al.The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection[J].J Infect Dis,2008,198(8):1180-1188.
[13] Bassetti M,Montero JG,Paiva JA.When antibiotic treatmentfails[J].Intensive Care Med,2018,44(1):73-75.
[14] 洪建国.糖皮质激素在重症支原体肺炎治疗中的应用[J].中国实用儿科杂志,2015,30(3):170-173.
[15] 林志雄,王开梅,陈江,等.不同剂量糖皮质激素辅助治疗小儿难治性肺炎支原体肺炎合并肺外并发症疗效比较[J].中国医院药学杂志,2017,37(7):639-642.
PDF(382 KB)

Accesses

Citation

Detail

Sections
Recommended

/